期刊文献+

HIV-1感染者CD4+CD25^nt/hi CD127^lo调节性T细胞PD-1表达水平与疾病进展的关系 被引量:7

Association of PD-1 expression on CD4^+ CD25^(nt/hi) CD127^(lo) regulatory T cells with disease progression in HIV-1 infected patients
下载PDF
导出
摘要 目的:阐明HIV-1感染者外周血中具有CD4+CD25nt/hiCD127lo特征的调节性T细胞(Treg)表面PD-1的表达水平与疾病进展的关系。方法:选取108名未经治疗的不同进展期的HIV-1感染者和27名健康人对照,采集静脉血,用Ficoll-Hypaque密度梯度离心法分离获得PBMC,加入PerCP-CD4抗体、FITC-CD25抗体、PE-CD127抗体和APC-PD-1抗体,经细胞表面四色染色、流式细胞术(FCM)分析Treg表面PD-1的表达;另将50 L全血加入Trucount绝对计数管,采用Multitest CD3/CD8/CD45/CD4试剂盒检测CD4+T细胞绝对数;分离静脉血血浆,NucliSens EasyQ测定血浆HIV-1病毒载量;实验数据采用SPSS14.0统计学软件分析处理。结果:HIV-1感染者Treg表面PD-1表达水平显著高于健康人(5.33%±2.24%vs1.72%±0.65%,P<0.01);AIDS期(7.87%±2.23%)明显高于进展期(5.21%±1.72%,P<0.05)和新近感染者(3.22%±1.01%,P<0.05);HIV-1感染者Treg表面PD-1表达水平与血浆中的HIV-1病毒载量和CD4+T细胞绝对数密切相关。结论:首次证实HIV-1感染者外周血中Treg表面PD-1表达增加,且表达水平与病程进展相关。该结果为进一步揭示HIV-1感染中Treg的效应机制、探索新的免疫治疗方案提供了理论及实验依据。 AIM: To investigate whether Programmed death-1 (PD-1) expression on peripheral CD4+ CD25^nt/hi CD127^lo regulatory T cells (Treg) was associated with disease progression in HIV-1-infected patients. METHODS: Peripheral blood from 108 HIV-1-infected patients in distinct disease progression statuses and 27 healthy individuals were collected in the present investigation. PBMCs were isolated by centrifugation on FicolI-Hypaque, followed by staining with anti-CD4-PerCP, anti-CD25-FITC, anti-CD127- PE and anti-PD-I-APC. PD-I expression on Treg was analyzed by four-color staining flow cytometry. CD4+ T cell absolute counts were determined using Multitest CD3/CD4/ CD8/CD45 kit and plasma viral loads were detected on NucliSens EasyQ. All data were analyzed using SPSS14.0 software. RESULTS: In peripheral blood of healthy individuals, Treg expressed PD-1 at very low levels (1.72% ±0.65%). In contrast, Treg from HIV-1-infected patients showed a significantly increased PD-1 expression (5.33% ± 2.24%, P 〈 0.01). Moreover, AIDS patients exhibited statistically higher PD-1 expression on Treg (7. 87% ± 2.23% ) than newly HIV-1 infected patients (3.22% ± 1.01%, P 〈 0.05) and patients in progression to AIDS(5.21% ± 1.72%, P〈0.05). PD-1 up-regulation on Treg was closely correlated with reduced CD4+ T cell absolute counts but elevated plasma viral load. CONCLUSION: Overall, we found that PD-1 expression on peripheral Treg was up-regulated and correlated with disease progression in HIV-1-infected patients for the first time. These findings not only extend our understanding of how Treg functions in HIV-1-infected patients but also support the notion that blocking PD-1/PD-L1 interactions may represent a potential therapeutic strategy for HIV-1-infected patients.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第11期1020-1022,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(30872256) 国家科技重大专项(2008ZX10001_002) 上海市自然科学基金资助项目(072R14091) 上海市医学重点学科建设项目(05Ⅲ029)
关键词 HIV-1 CD4+CD25+调节性T细胞 CD127 PD-1 HIV-1 CD4+ CD25 regulatory T cell CD127 PD-1
  • 相关文献

参考文献11

  • 1Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance[J].Cell, 2000, 101 (5) : 455 -458.
  • 2Sakaguchi S. Regulatory T cells in the past and for the future[ J]. Eur J Immunol, 2008, 38(4): 901 -937.
  • 3Rouse BT, Sarangi PP, Suvas S. Regulatory T ceils in virus infections [J]. Immunol Rev, 2006, 212:272-286.
  • 4Hazenberg MD, Otto SA, van Benthem MH, et al. Persistent inunune activation in HIV-1 infection is associated with progression to AIDS [J].AIDS, 2003, 17(13): 1881-1888.
  • 5Kinter AL, Hennessey M, Bell A, et al. CD25^+ CD4^+ regulatory T- cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4^ and CD8 + HIV-specific T-cell immune responses in vitro and are associated with favorable clinical markers of disease status [J]. J Exp Med, 2004, 200(3): 331 -343.
  • 6Oestreich KJ, Yoon H, Ahmed R, et al. NFATcl regulates PD-1 expression upon T cell activation[J]. J Immunol, 2008, 181 (7) : 4832 - 4839.
  • 7Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited[J]. Annu Rev Immunol, 2005, 23 : 515 -548.
  • 8Jinushi M, Takehara T, Tatsumi T, et al. Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1 -dependent regulatory activities [J]. Immunology, 2007, 120(1) : 73 -82.
  • 9Yang Z, Wang S, Zhang J, et al. Expression of PD-1 is up-regulated in CD4^+ CD25^+ FoxP3^+ regulatory T cell of non-responders after hepatitis B surface antigen vaccine immunization [ J]. Clin lmmunol, 2008, 129(1): 176-177.
  • 10Raimondi G, Shufesky WJ, Tokita D, et al. Regulated compartmentalization of programmed cell death-1 discriminates CD4^+ CD25^+ resting regulatory T cells from activated T cells [J]. J Immunol, 2006, 176(5) : 2808 -2816.

同被引文献52

  • 1Liang, Xue-Song,Zhou, Ying,Li, Chen-Zhong,Wan, Mo-Bin.Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells[J].World Journal of Gastroenterology,2010,16(5):618-624. 被引量:16
  • 2刘水腾,杨桂林,姚红艳,李美忠,徐六妹,李丽雄,王火生,周伯平.CD4^+CD25^+调节性T细胞在HIV/AIDS患者中的作用及其与HIV病毒载量的相关性研究[J].中华实验和临床病毒学杂志,2006,20(4):364-366. 被引量:8
  • 3Onno M, Pangault C, Le Friec G, et al. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induc- tion in activated macrophages harboring human cytomegalovirus infection J 1. J Immuno1,2000,164 ( 12 ) :6426 - 6434.
  • 4Skiest D J, Chiller T, Chiller K, et al. Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis [ J ]. In- ternational Journal of STD and AIDS ,2011,12:659 - 664.
  • 5Shi Y, Lu HZ, He TW, et al. Prevalence and clinical manage- ment of cytomegalovirus retinitis in AIDS patients in Shanghai, China J. BMC Infect Dis ,2011,11:326 - 334.
  • 6Ferreyra C, Yun O, Eisenberg N, et al. Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya J ]. PLoS One, 2012,7 ( 11 ) : e49834.
  • 7May G, Kuhn JE, Eing BR. Comparison of two commercially available pp65 antigenemia tests and COBAS amplicor CMV monitor for early detection and quantification of episodes of hu- man CMV-viremia in transplant recipients E J 1. Intervirology, 2006,49 (5) :261 - 265.
  • 8Seehofer D, Meisel H, Rayes N, et al. Prospective evaluation of the clinical utility of different methods for the detection of hu- man cytomegalovims disease after liver transplantation [ J ]. Am J Transplant,2004,4(8) :1331 - 1337.
  • 9Kim CK, Song JH, Kim SM, et ai. Clinical usefulness of human cytomegalovims anfigenemia assay after kidney transplantation [ J]. Transplantation,2003,75 ( 12 ) :2151 - 2155.
  • 10Kaiejta RF. Tegument proteins of human cytomegalovirus I J ]. Microbiol Mol Biol Rev ,2008,72 ( 2 ) :249 - 265.

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部